RTW Biotech Opportunities (LON:RTW – Get Free Report) shares traded up 0.3% on Monday . The stock traded as high as GBX 1.56 ($0.02) and last traded at GBX 1.54 ($0.02). 103,208 shares traded hands during mid-day trading, a decline of 85% from the average session volume of 679,371 shares. The stock had previously closed at GBX 1.54 ($0.02).
RTW Biotech Opportunities Stock Up 0.3 %
The company’s fifty day simple moving average is GBX 1.40 and its two-hundred day simple moving average is GBX 1.36. The company has a market capitalization of £5.92 million, a price-to-earnings ratio of 4.28 and a beta of 0.60.
RTW Biotech Opportunities Company Profile
RTW Biotech Opportunities Ltd is a venture capital fund. The fund specializes in directly investing and early-stage. The fund specializes in identifying transformative assets with high growth potential across the life sciences, biopharmaceutical and medical technology sectors. The fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.
See Also
- Five stocks we like better than RTW Biotech Opportunities
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- The Top 3 Sectors Poised For Growth This Summer
- What Are Trending Stocks? Trending Stocks Explained
- U.S. Steel Stock: Betting on EPS Cut and Merger Uncertainty?
- Consumer Staples Stocks, Explained
- GitLab Stock: Pioneering the AI-Powered DevSecOps Platform
Receive News & Ratings for RTW Biotech Opportunities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTW Biotech Opportunities and related companies with MarketBeat.com's FREE daily email newsletter.
